TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2024

Income Metrics

Revenue 53.0M
Gross Profit 2.8M 5.24%
Operating Income 1.3M 2.39%
Net Income 1.5M 2.79%
EPS (Diluted) ₹0.15

Balance Sheet Metrics

Total Assets 272.1M

Cash Flow Metrics

Revenue & Profitability Trend

Trimurthi Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i307.2M42.2M14.0M8.4M92.4M
Cost of Goods Sold i295.7M38.4M13.5M8.1M85.7M
Gross Profit i11.4M3.9M523.6K349.9K6.8M
Gross Margin % i3.7%9.2%3.7%4.1%7.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-1.0M855.7K822.8K2.0M
Other Operating Expenses i9.3M2.2M1.5M1.5M2.6M
Total Operating Expenses i9.3M3.3M2.4M2.3M4.6M
Operating Income i1.1M-1.5M-5.7M-5.9M-10.4M
Operating Margin % i0.3%-3.5%-40.9%-69.9%-11.3%
Non-Operating Items
Interest Income i-2.0M2.7M3.0M3.3M
Interest Expense i---577.0K540.0K
Other Non-Operating Income-----
Pre-tax Income i1.2M212.6K-584.8K-15.7M-37.5M
Income Tax i388.0K108.4K14.5K-54.7K138.0K
Effective Tax Rate % i31.5%51.0%0.0%0.0%0.0%
Net Income i845.0K104.1K-599.3K-15.6M-37.6M
Net Margin % i0.3%0.2%-4.3%-185.1%-40.7%
Key Metrics
EBITDA i1.5M-748.2K-7.6M7.6M-5.3M
EPS (Basic) i-₹0.01₹-0.07₹-1.93₹-4.62
EPS (Diluted) i-₹0.01₹-0.07₹-1.93₹-4.62
Basic Shares Outstanding i-8100000810000081000008100000
Diluted Shares Outstanding i-8100000810000081000008100000

Income Statement Trend

Trimurthi Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i-1.2M2.7M26.0M20.8M
Short-term Investments i-25.0M25.0M4.0M5.8M
Accounts Receivable i-133.6K1.9M998.0K13.8M
Inventory i-11.9M8.2M5.3M9.3M
Other Current Assets---10-20-
Total Current Assets i-41.3M42.4M46.3M73.3M
Non-Current Assets
Property, Plant & Equipment i-01.4M1.4M123.0K
Goodwill i-1001000325.0K
Intangible Assets i-100100106.0K325.0K
Long-term Investments-----
Other Non-Current Assets---11013.6M
Total Non-Current Assets i2.7M32.4M30.1M26.2M22.4M
Total Assets i2.7M73.6M72.6M72.5M95.7M
Liabilities
Current Liabilities
Accounts Payable i-30.0K538.0K021.5M
Short-term Debt i---337.0K0
Current Portion of Long-term Debt-----
Other Current Liabilities-71.3K-131.0K289.0K
Total Current Liabilities i-101.4K616.4K81.5K21.8M
Non-Current Liabilities
Long-term Debt i0--1.3M0
Deferred Tax Liabilities i-000328.0K
Other Non-Current Liabilities----1.0K
Total Non-Current Liabilities i-000329.0K
Total Liabilities i-101.4K616.4K81.5K22.1M
Equity
Common Stock i-81.0M81.0M81.0M81.0M
Retained Earnings i--24.1M-24.3M-23.7M-27.4M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-73.5M72.0M72.4M73.7M
Key Metrics
Total Debt i0001.6M0
Working Capital i041.2M41.8M46.2M51.6M

Balance Sheet Composition

Trimurthi Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-212.6K-584.8K-15.7M-37.3M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i0-440.0K-19.4M11.4M50.2M
Operating Cash Flow i-159.0K-2.3M-22.7M-7.3M10.3M
Investing Activities
Capital Expenditures i-184.6K-43.8K-18.3M-295.0K
Acquisitions i-----
Investment Purchases i----500.0K-2.8M
Investment Sales i--22.8M15.6M1.7M
Investing Cash Flow i-184.6K-4.4M-3.3M-1.4M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i113.2M--00
Free Cash Flow i--3.4M-24.1M-12.7M15.6M
Net Change in Cash i113.0M-2.1M-27.1M-10.6M8.9M

Cash Flow Trend

Trimurthi Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 102.35
Price to Book 2.40
Price to Sales 2.45

Profitability Ratios

Profit Margin 1.85%
Operating Margin 2.41%
Return on Assets 30.90%

Financial Health

Beta 0.62

Per Share Data

EPS (TTM) ₹0.26
Book Value per Share ₹11.10
Revenue per Share ₹11.72

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
trimurthi264.8M102.352.400.00%1.85%-
Entero Healthcare 51.9B54.823.015.36%1.90%21.76
Amwill Health Care 1.2B8.971.7224.85%26.44%0.00
Royal Sense 1.1B17.333.6227.55%10.26%11.74
NOVELIX 532.4M514.502.340.68%0.28%0.00
Zenlabs Ethica 214.6M78.021.992.62%0.52%121.85

Financial data is updated regularly. All figures are in the company's reporting currency.